Media coverage
3
Media coverage
Title Protagonist Therapeutics to Present Updated Phase 2 Rusfertide Clinical Results in Polycythemia Vera (PV) at ASCO 2022 Media name/outlet Elk Valley Times Country/Territory United States Date 26/05/22 URL https://www.elkvalleytimes.com/news/business/protagonist-therapeutics-to-present-updated-phase-2-rusfertide-clinical-results-in-polycythemia-vera-pv-at/article_6ef5b236-f575-501c-8590-84824d16910b.html Persons Ronald Hoffman Title Protagonist Therapeutics to Present Updated Phase 2 Rusfertide Clinical Results in Polycythemia Vera (PV) at ASCO 2022 Media name/outlet Herald Chronicle Country/Territory United States Date 26/05/22 URL https://www.heraldchronicle.com/news/business/protagonist-therapeutics-to-present-updated-phase-2-rusfertide-clinical-results-in-polycythemia-vera-pv-at/article_3c9db5ac-1b1d-55cd-a633-e575852a9286.html Persons Ronald Hoffman Title Protagonist Therapeutics to Present Updated Phase 2 Rusfertide Clinical Results in Polycythemia Vera (PV) at ASCO 2022 Media name/outlet Manchester Times Country/Territory United States Date 26/05/22 URL https://www.manchestertimes.com/news/business/protagonist-therapeutics-to-present-updated-phase-2-rusfertide-clinical-results-in-polycythemia-vera-pv-at/article_3ebaffd8-bc84-506c-99a0-5f53da9a4f18.html Persons Ronald Hoffman